Publications by authors named "Joshua Prey"

Claim this Profile
P
Preclinical experience with cisplatin, gemcitabine, and doxorubicin in pulmonary suffusion.
Lindsay J Nitsche, Leslie Curtin, Sandra Sexton, Thaer Khoury, Joshua D Prey

JTCVS Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
Theresa A Hess, Macy E Drinkhouse, Joshua D Prey, Jonathan M Miller, Arthur A Fettig

J Am Vet Med Assoc· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study.
Ramesh K Ramanathan, Ronald L Korn, Natarajan Raghunand, Jasgit C Sachdev, Ronald G Newbold, Joshua Prey

Clin Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma.
Jennifer L Clarke, Annette M Molinaro, Juan R Cabrera, Ashley A DeSilva, Jane E Rabbitt, Joshua Prey

Cancer Chemother Pharmacol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models.
Xiang Ling, Xiaojun Liu, Kai Zhong, Nicholas Smith, Joshua Prey

Am J Transl Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model.
Bonnie L Hylander, Arindam Sen, Sarah H Beachy, Rose Pitoniak, Soumya Ullas, Joshua D Prey

J Control Release· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients.
Kathleen M Tornatore, Calvin J Meaney, Gregory E Wilding, Shirley S Chang, Aijaz Gundroo, Joshua Prey

Clin Pharmacokinet· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications.
Remi Adelaiye, Eric Ciamporcero, Kiersten Marie Miles, Paula Sotomayor, Jonathan Bard, Joshua Prey

Mol Cancer Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models.
Deepika Lal, Jennifer A Park, Kellie Demock, Joseph Marinaro, Amanda M Perez, Joshua Prey

Mol Cancer Ther· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of serum iohexol clearance for use in predicting carboplatin clearance in cats.
Dennis B Bailey, Kenneth M Rassnick, Joshua D Prey, Nathan L Dykes

Am J Vet Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.
Milind M Javle, Gary Yang, Chumy E Nwogu, Gregory E Wilding, Linda O'Malley, Joshua D Prey

Cancer Invest· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors.
Marwan G Fakih, Lakshmi Pendyala, William Brady, Patrick F Smith, Mary E Ross, Joshua D Prey

Cancer Chemother Pharmacol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent.
Rami G Azrak, Shousong Cao, Lakshmi Pendyala, Farukh A Durrani, Marwan Fakih, Joshua Prey

Biochem Pharmacol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic measurements of IDN 5390 using electrospray ionization tandem mass spectrometry: structure characterization and quantification in dog plasma.
Liguo Song, Joshua D Prey, Jun Xue, Peter Kanter, Carla Manzotti

Rapid Commun Mass Spectrom· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors.
Marwan G Fakih, Lakshmi Pendyala, Patrick F Smith, Patrick J Creaven, Mary E Reid, Joshua D Prey

Clin Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyamine catabolism in platinum drug action: Interactions between oxaliplatin and the polyamine analogue N1,N11-diethylnorspermine at the level of spermidine/spermine N1-acetyltransferase.
Suzanne Hector, Carl W Porter, Debora L Kramer, Kimberly Clark, Joshua Prey

Mol Cancer Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis